BACKGROUND: Application of the reverse transcriptase polymerase chain reaction (RT-PCR) to identification of circulating tumour cells in colorectal cancer. AIMS: To assess whether circulating malignant cells in patients with colorectal liver metastasis could be identified by RT-PCR recognition of mRNA coding for the tumour marker carcinoembryonic antigen (CEA). PATIENTS: A total of 31 with colorectal liver metastases and 22 no-cancer controls. METHODS: Specific cDNA primers for CEA transcripts were used to apply RT-PCR to tissue biopsy specimens, colon carcinoma cell lines, and peripheral blood samples from patients with colorectal liver metastases. A strongly CEA-expressive HT115 colorectal carcinoma cell line was used to spike blood samples from no-cancer control subjects. RESULTS: The limit for detection of CEA cDNA by Southern blotting using HT115 cells was 50 cells per 14 ml of spiked blood. There was a significant difference (p = 0.007) in RT-PCR positive expression between patients with liver metastasis (26/31) compared with controls (5/22). There was no significant relation between the prevalence of CEA cDNA amplification and serum CEA level or metastasis volume in patients with liver metastasis. CONCLUSIONS: This is the first study to suggest that identification of circulating colorectal cancer cells using RT-PCR for detection of CEA cDNA is feasible.
BACKGROUND: Application of the reverse transcriptase polymerase chain reaction (RT-PCR) to identification of circulating tumour cells in colorectal cancer. AIMS: To assess whether circulating malignant cells in patients with colorectal liver metastasis could be identified by RT-PCR recognition of mRNA coding for the tumour marker carcinoembryonic antigen (CEA). PATIENTS: A total of 31 with colorectal liver metastases and 22 no-cancer controls. METHODS: Specific cDNA primers for CEA transcripts were used to apply RT-PCR to tissue biopsy specimens, colon carcinoma cell lines, and peripheral blood samples from patients with colorectal liver metastases. A strongly CEA-expressive HT115 colorectal carcinoma cell line was used to spike blood samples from no-cancer control subjects. RESULTS: The limit for detection of CEA cDNA by Southern blotting using HT115 cells was 50 cells per 14 ml of spiked blood. There was a significant difference (p = 0.007) in RT-PCR positive expression between patients with liver metastasis (26/31) compared with controls (5/22). There was no significant relation between the prevalence of CEA cDNA amplification and serum CEA level or metastasis volume in patients with liver metastasis. CONCLUSIONS: This is the first study to suggest that identification of circulating colorectal cancer cells using RT-PCR for detection of CEA cDNA is feasible.
Authors: H Schrewe; J Thompson; M Bona; L J Hefta; A Maruya; M Hassauer; J E Shively; S von Kleist; W Zimmermann Journal: Mol Cell Biol Date: 1990-06 Impact factor: 4.272
Authors: J Thompson; S Mössinger; V Reichardt; U Engels; N Beauchemin; F Kommoss; S von Kleist; W Zimmermann Journal: Int J Cancer Date: 1993-09-09 Impact factor: 7.396
Authors: M Matsumura; Y Niwa; N Kato; Y Komatsu; S Shiina; T Kawabe; T Kawase; H Toyoshima; M Ihori; Y Shiratori Journal: Hepatology Date: 1994-12 Impact factor: 17.425
Authors: M V Seiden; P W Kantoff; K Krithivas; K Propert; M Bryant; E Haltom; L Gaynes; I Kaplan; G Bubley; W DeWolf Journal: J Clin Oncol Date: 1994-12 Impact factor: 44.544
Authors: R S Israeli; W H Miller; S L Su; C T Powell; W R Fair; D S Samadi; R F Huryk; A DeBlasio; E T Edwards; G J Wise Journal: Cancer Res Date: 1994-12-15 Impact factor: 12.701
Authors: Ulrich Guller; Paul Zajac; Annelies Schnider; Beatrix Bösch; Stefan Vorburger; Markus Zuber; Giulio Cesare Spagnoli; Daniel Oertli; Robert Maurer; Urs Metzger; Felix Harder; Michael Heberer; Walter Richard Marti Journal: Ann Surg Date: 2002-12 Impact factor: 12.969
Authors: Hitesh Patel; Nadia Le Marer; Richard Q Wharton; Zulfiqar A J Khan; Ruth Araia; Clare Glover; Michael M Henry; Timothy G Allen-Mersh Journal: Ann Surg Date: 2002-02 Impact factor: 12.969
Authors: X Bessa; A Castells; A M Lacy; J I Elizalde; S Delgado; L Boix; V Piñol; M Pellisé; J C García-Valdecasas; J M Piqué Journal: J Gastrointest Surg Date: 2001 Jan-Feb Impact factor: 3.452
Authors: Xavier Bessa; Virgínia Piñol; Sergi Castellví-Bel; Elena Piazuelo; Antonio M Lacy; J Ignasi Elizalde; Josep M Piqué; Antoni Castells Journal: Ann Surg Date: 2003-03 Impact factor: 12.969